Page last updated: 2024-10-24

cellular response to L-glutamine

Definition

Target type: biologicalprocess

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-glutamine stimulus. [GO_REF:0000071, GOC:TermGenie, PMID:23185570]

L-glutamine is a non-essential amino acid that plays a crucial role in cellular metabolism. It is involved in a wide range of cellular processes, including protein synthesis, energy production, and the biosynthesis of nucleotides. The cellular response to L-glutamine begins with its uptake into the cell via the glutamine transporter. Once inside the cell, L-glutamine can be used for a variety of metabolic pathways. One of the most important pathways is the synthesis of glutamate, which is a precursor for the neurotransmitter GABA. Glutamine can also be used to synthesize other amino acids, such as proline and arginine. In addition, L-glutamine can be used as an energy source by the cell. It is broken down into alpha-ketoglutarate, which enters the Krebs cycle. The Krebs cycle is a central metabolic pathway that produces energy for the cell. L-glutamine also plays a role in the biosynthesis of nucleotides. It is used to synthesize the amino acids adenine and guanine, which are components of DNA and RNA. In addition, L-glutamine is involved in the regulation of cell growth and proliferation. It is important for the synthesis of proteins and DNA, both of which are essential for cell growth. The cellular response to L-glutamine is complex and involves a variety of metabolic pathways. It is essential for a wide range of cellular functions, including protein synthesis, energy production, and the biosynthesis of nucleotides. L-glutamine also plays a role in the regulation of cell growth and proliferation.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Heat shock factor protein 1A heat shock factor protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q00613]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
zm 336372N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first sourcebenzamides
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
chir-265aromatic ether
az-628AZ-628: a multikinase inhibitor; structure in first sourcebenzamides
GDC-0879indanes;
ketoxime;
primary alcohol;
pyrazoles;
pyridines
antineoplastic agent;
B-Raf inhibitor
plx4032aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
dabrafenib1,3-thiazoles;
aminopyrimidine;
organofluorine compound;
sulfonamide
anticoronaviral agent;
antineoplastic agent;
B-Raf inhibitor
tak-632TAK-632 : A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by (cyclopropanecarbonyl)amino, 4-fluoro-3-{2-[3-(trifluoromethyl)phenyl]acetamido}phenoxy, and cyano groups at positions 2, 6 and 7, respectively. It is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF(V600E), BRAF(WT), respectively.(trifluoromethyl)benzenes;
aromatic ether;
benzothiazoles;
cyclopropylcarboxamide;
monofluorobenzenes;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
necroptosis inhibitor
dinaciclibpyrazolopyrimidine
n2-(1h-indazole-5-yl)-n6-methyl-3-nitropyridine-2,6-diamineKRIBB11 : A member of the class of indazoles that is 1H-indazole substituted by a [6-(methylamino)-3-nitropyridin-2-yl]amino group at position 5. It is an inhibitor of heat shock factor 1 (IC50 = 1.2muM) and suppresses tumour growth in mouse xenograft models.

N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine: a heat shock factor 1 antagonist; structure in first source